Breaking News

Aptuit Appoints CEO

December 2, 2013

Goldman to establish new partnerships and pursue strategic acquisitions

Jonathan Goldman, M.D. has been appointed chief executive officer of Aptuit LLC. Dr. Goldman will focus his efforts on the growth of early development services by establishing new partnerships and pursuing strategic acquisitions. He joins the company from ICON Clinical Research, where he served as executive vice president, global strategic and business development and a member of the senior leadership team.
While at ICON, his accomplishments included record growth levels of sales, and the development of business relationships with leading pharma and biopharma companies. Previously, he served as ICON’s executive vice president, operations, strategic programs and chief medical officer, ICON Medical Imaging. Before ICON, Dr. Goldman served as chief medical officer of POINT Biomedical for seven years. He also held honorary academic positions of increasing responsibility at the University of California, most recently as associate Clinical Professor of Medicine in the Division of Cardiology. 
Timothy C. Tyson, chairman of Aptuit, said, "We're enthusiastic that Jonathan is joining us. He brings exceptional experience in science, sales and medicine, along with the innate talents that are needed to advance us to the next level of growth and accomplishments. His collaborative approach to understanding and satisfying the unmet needs of our clients makes him the perfect complement to our senior management team."
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus